about
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...
Read More
349.68
6.08
(1.77%)
984.5K
XNAS Volume
XNAS 22 Jan, 2026 11:42 AM (EST)
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Amgen Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..